Thesis advisor: Steven D. Bruner / Thesis advisor: Larry W. McLaughlin / Nonribosomal peptides are therapeutically important natural products produced through pathways that utilize large multimodular enzymes, termed nonribosomal peptide synthetases (NRPSs). Central to the assembly line methodology, the monomer building blocks and the growing polymer chain are covalently linked to dedicated peptidyl carrier protein domains as phosphopantetheinyl thioesters. Although structures of multidomain NRPS fragments have been solved recently, the active conformation of the carrier domains with their attached phosphopantetheinyl arms has not been determined. Significant conformational changes in carrier domains are likely to occur as the domains shuttle peptidyl phosphopantetheinyl thioesters between the active sites of the partner domains. This thesis focuses on the application of the synthetic isosteric non-hydrolyzable CoA analogs to manipulate carrier domain geometry of NRPS assemblies through. The synthetic conjugates are designed to deliver an inhibitor moiety to a domain of interest. Using this strategy, various complexes have been designed to direct the phosphopantetheinyl arm to active sites of adenylation domains and thioesterase domains in catalytically relevant conformations. The structurally restrained multidomain NRPS assemblies are useful for elucidating the complex structure and mechanism of NRPSs. An X-ray crystal structure of a peptidyl carrier-thioesterase NRPS didomain fragment from enterobactin synthetase has been solved with a phosphopantetheinyl analog which forms a cross-link between the two domains. This structure provides, for the first time, detailed insights into the phosphopantetheinyl arm interaction with an NRPS partner domain, as well as an active confirmation of a mutidomain NRPS in the holo-form. In addition, the hydrolytically stable CoA analogs have been successfully used as probes in the structural and mechanistic study of a CoA-utilizing enzyme DpgC, a unique cofactor-independent dioxygenase involved in vancomycin biosynthesis. / Thesis (PhD) — Boston College, 2009. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Chemistry.

Thesis advisor: Steven D. Bruner / Peptidic natural products are produced by diverse organisms ranging from bacteria to humans. These secondary metabolites can be assembled by the ribosome or by nonribosomal peptide synthetase (NRPS) enzymatic assembly lines. The architectural complexity and biological activity of such compounds make them interesting targets for study. Frequently, nonribosomal peptides contain nonproteinogenic amino acid building blocks, and the biosynthetic routes to both ribosomal and nonribosomal peptides often utilize tailoring enzymes. These specialized enzymes catalyze mechanistically challenging reactions and provide peptidic natural products with structural motifs not normally found in proteins. Structural studies of these tailoring enzymes will further our understanding of biosynthetic pathways, and engineered tailoring enzymes could find use as promiscuous catalysts for the chemoenzymatic synthesis of natural product analogs. The L-tyrosine 2,3-aminomutase <italic>Sg</italic>TAM catalyzes the formation of &beta;-tyrosine from L-tyrosine, and is used in the biosynthetic pathway to the enediyne antitumor antibiotic C-1027. This enzyme contains the rare electrophilic prosthetic group 4-methylideneimidazole-5-one (MIO) and is homologous to the histidine ammonia lyase family of enzymes. While lyases form &alpha;,&beta;-unsaturated carboxylates as products, <italic>Sg</italic>TAM catalyzes additional chemical steps that result in an overall 2,3-amino shift. The precise mechanistic role of MIO in the ammonia lyase and aminomutase families of enzymes was actively debated for over 50 years. Here, we report the first x-ray crystal structure of an MIO-dependent aminomutase and detail the synthesis and characterization of mechanistic probes for this enzyme. Furthermore, we report several structures of <italic>Sg</italic>TAM bound to substrate analogs. These co-crystal structures reveal how <italic>Sg</italic>TAM achieves substrate recognition and suggest a specific role for MIO in catalysis. The results of our studies allow for the rational engineering of MIO-based aminomutases and ammonia lyases with altered physical properties and substrate specificities. Additionally, we are currently studying several enzymes involved in the biosynthesis of the tricyclic depsipeptide microviridin J. This ribosomal peptide natural product contains two lactones and one lactam, which are introduced by two enzymes belonging to the ATP-grasp ligase superfamily of proteins. Here, we detail the overexpression of these enzymes, MdnJ-B and MdnJ-C, in <italic>E. coli</italic> and report the optimization of conditions which lead to the crystallization of both enzymes. The structural characterization of MdnJ-B and MdnJ-C will lead to a greater understanding of macrocycle formation in ribosomal peptide biosynthesis, and engineered variants of these enzymes may find use as macrocylcization catalysts. / Thesis (PhD) — Boston College, 2009. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Chemistry.

Thesis advisor: Steven D. Bruner / Thesis advisor: Mary F. Roberts / The fuscachelins are a group of novel small molecule secondary metabolites produced by the thermophilic actinomycete <italic>Thermobifida fusca</italic>. A genome mining approach was employed to identify the fuscachelin nonribosomal peptide synthetase biosynthetic gene cluster in <italic>T. fusca</italic>. The peptide natural products were predicted to be siderophores, iron-scavenging small molecules. An assay guided fractionation approach was utilized to isolate the fuscachelins. Structure elucidation efforts employed nuclear magnetic resonance, mass spectrometric and chemical degradation techniques to determine the structure of the isolated compounds. Once the structure was known, a total synthesis was undertaken. The established synthetic route to the fuscachelins will allow for the facile development of custom-designed chemical tools for the further study of the fuscachelin biosynthetic enzymes and utilization proteins. / Thesis (PhD) — Boston College, 2010. / Submitted to: Boston College. Graduate School of Arts and Sciences. / Discipline: Chemistry.

Nonribosomal peptides (NRP) are highlighted in pharmacological studies as novel NRPs are often promising substances for new drug development. To effectively discover novel NRPs from microbial fermentations, a crucial step is to identify known NRPs in an early stage and exclude them from further investigation. This so-called dereplication step ensures the scarce resource is only spent on the novel NRPs in the following up experiments. Tandem mass spectrometry has been routinely used for NRP dereplication. However, few bioinformatics tools have been developed to computationally identify NRP compounds from mass spectra, while manual identification is currently the roadblock hindering the throughput of novel NRP discovery. In this thesis, we review the nature of nonribosomal peptides and investigate the challenges in computationally solving the identification problem. After that, iSNAP software is proposed as an automated and high throughput solution for tandem mass spectrometry based NRP identification. The algorithm has been evolved from the traditional database search approach for identifying sequential peptides, to one that is competent at handling complicated NRP structures. It is designed to be capable of identifying mixtures of NRP compounds from LC-MS/MS of complex extract, and also finding structural analogs which differ from an identified known NRP compound with one monomer. Combined with an in-house NRP structural database of 1107 compounds, iSNAP is tested to be an effective tool for mass spectrometry based NRP identification. The software is available as a web service at http://monod.uwaterloo.ca/isnap for the research community.

Nonribosomal peptides (NRP) are highlighted in pharmacological studies as novel NRPs are often promising substances for new drug development. To effectively discover novel NRPs from microbial fermentations, a crucial step is to identify known NRPs in an early stage and exclude them from further investigation. This so-called dereplication step ensures the scarce resource is only spent on the novel NRPs in the following up experiments. Tandem mass spectrometry has been routinely used for NRP dereplication. However, few bioinformatics tools have been developed to computationally identify NRP compounds from mass spectra, while manual identification is currently the roadblock hindering the throughput of novel NRP discovery. In this thesis, we review the nature of nonribosomal peptides and investigate the challenges in computationally solving the identification problem. After that, iSNAP software is proposed as an automated and high throughput solution for tandem mass spectrometry based NRP identification. The algorithm has been evolved from the traditional database search approach for identifying sequential peptides, to one that is competent at handling complicated NRP structures. It is designed to be capable of identifying mixtures of NRP compounds from LC-MS/MS of complex extract, and also finding structural analogs which differ from an identified known NRP compound with one monomer. Combined with an in-house NRP structural database of 1107 compounds, iSNAP is tested to be an effective tool for mass spectrometry based NRP identification. The software is available as a web service at http://monod.uwaterloo.ca/isnap for the research community.

<p>Nonribosomal peptides (NRPs) are a major class of natural products known for their biological activities and are employed therapeutically as immunosupressants, anticancer agents, and antibiotics. Nonribosomal peptides are microbial products, biosynthesized by large assembly line-like enzymes, known as nonribosomal peptide synthetases (NRPSs) that can be found in large gene clusters within the genome. With the advent of genome sequencing, the gene clusters for known NRPs are easily identified within producing organisms, but more strikingly, this sequencing reveals that microbes often contain many gene clusters with no known products suggesting traditional methods of isolation are overlooking the majority of NRPs.</p> <p>Extensive studies of NRPS functions have revealed assembly line logic for the biosynthesis of NRPs and using this knowledge, the NRP products of NRPS gene clusters can be predicted. In this research, products from both a simple dimodular NRPS from <em>Staphylococcus aureus </em>and a complex 11 module NRPS from <em>Delftia acidovorans </em>were predicted and used to successfully identify and isolate two novel NRPs, aureusimine and delftibactin.<em> </em>Theses compounds fell outside traditional NRP activities, one being a virulence regulator and the other a gold-complexing metallophore. Subsequent biosynthetic studies of the aureusimine gene cluster within the heterologous host, <em>Escherichia coli</em>, provide insight into NRPS flexibility for the creation of NRP natural variants and highlighted the utility of <em>E. coli </em>for the heterologous production of NRPs.</p> <p>Realizing single NRP predictions are not always accurate, a strategy was devised to use a genomically predicted NRP fragment barcode databases with the LC-MS/MS dereplication algorithm, iSNAP, to chemoinformatically identify and physically locate genetically predicted NRPs within crude extracts. This final contribution eliminates the need for bioactivity guided approaches to discovery and provides a strategy to systematically discover all predicted NRPs from cryptic gene clusters. This thesis delivers strategies and technologies for the directed discovery of NRPs from microbial sources.</p> / Doctor of Philosophy (PhD)

Alternaria brassicicola is a necrotrophic pathogen that causes black spot disease on virtually all cultivated Brassicas, A. brassicicola is renowned for its ability to prodigiously produce secondary metabolites. To test the hypothesis that secondary metabolites produced by A. brassicicola contribute to pathogenicity, we identified seven nonribosomal peptide synthetases (NPSs) and 10 polyketide synthases (PKSs) in the A. brassicicola genome. The phenotype resulting from knockout mutations of each PKS and NPS gene was investigated with an emphasis on discovery of fungal virulence factors. A highly efficient gene disruption method using a short linear double stranded DNA construct with minimal elements was developed, optimized, and used to functionally disrupt all NPS and PKS genes in A. brassicicola. Three NPS and two PKS genes, and one NPS-like gene appeared to be virulence factors based upon reduced lesion development of each mutant on inoculated green cabbage and Arabidopsis compared with the wild-type strain. Furthermore some of the KO mutants exhibited developmental phenotypic changes in pigmentation and conidiogenesis. To further characterize the roles of several genes of interest in A. brassicicola development and pathogenesis, the genes AbNPS2, AbPKS9, and NPS-like tmpL were selected for in-depth functional analysis. We provide substantial evidence that the AbNPS2-associated metabolite is involved in conidial cell wall construction, possibly as an anchor connecting two cell wall layers. We also characterized a biosynthetic gene cluster harboring the AbPKS9 gene and demonstrated that this cluster is responsible for the biosynthesis of depudecin, an inhibitor of histone deacetylases and a minor virulence factor. Finally, we demonstrated that a NPS-like protein named TmpL is involved in a filamentous fungi-specific mechanism for regulating levels of intracellular reactive oxygen species during conidiation and pathogenesis in both plant and animal pathogenic fungi. Collectively our results indicate that small molecule nonribosomal peptides and polyketides in A. brassicicola play diverse, but also fundamental, roles in fungal development and pathogenesis. / Ph. D.

Fischerella é um gênero cianobacteriano de ocorrência em diversos ambientes subaerofíticos que apresenta importância ecológica, evolutiva, biogeoquímica, biotecnológica e ecotoxicológica. O estudo de seu genoma pode levar a uma melhor compreensão de seu metabolismo secundário e de sua capacidade de produção de cianotoxinas e outras moléculas bioativas. A linhagem Fischerella CENA161, isolada de uma nascente de água na região de Piracicaba, foi identificada como produtora do peptídeo hepatotóxico microcistina. Este foi o primeiro relato da produção dessa toxina por esse gênero de cianobactéria. Dessa maneira, este trabalho teve como objetivo sequenciar o genoma da cianobactéria Fischerella CENA161 e realizar sua montagem e a anotação de genes envolvidos com seu metabolismo secundário. Para isso, a linhagem foi tratada com hipoclorito de sódio para remover as bactérias heterotróficas, com posterior esgotamento de pequenos fragmentos em placa de cultura sólida, de forma a isolar a linhagem. Foi realizada a extração de ácido desoxirribonucleico das células tratadas da CENA161 cultivadas em Erlenmeyers contendo meio de cultura líquido BG-110. Uma biblioteca genômica foi construída para o sequenciamento MiSeq e, então, foi realizada a montagem ab initio do genoma com as leituras obtidas. A anotação de genes foi realizada utilizando a ferramenta antiSMASH, para a predição de metabólitos secundários, e também foi realizado o alinhamento de sequências nucleotídicas já conhecidas de outras linhagens contra o genoma da CENA161, utilizando a ferramenta BLASTN. As moléculas bioativas produzidas pela linhagem foram investigadas através de bioensaios contra bactérias e fungo, e utilizando cromatografia líquida de alta pressão e espectrometria de massas. Os resultados mostraram que a linhagem CENA161 possui, em seu genoma, o agrupamento gênico de biossíntese da microcistina, apresentando os 10 genes descritos primeiramente (mcyA-mcyJ), e alta identidade de suas sequências com as sequências da linhagem Fischerella sp. PCC 9339, embora sua sintenia gênica esteja mais próxima à da linhagem Nostoc sp. 152. Ainda, foram anotados os agrupamentos gênicos de biossíntese de ambiguina (amb), apresentando 25 genes do total de 32 genes descritos para a linhagem Fischerella sp. UTEX 1903, com identidade mínima de 98 % entre as sequências nucleotídicas. Foram encontrados, também, seis genes do total de oito que formam o agrupamento de biossíntese de nostopeptolida (nos), descrito para Nostoc sp. GSV224, e com sintenia diferenciada para a linhagem CENA161. As análises químicas de espectrometria de massas mostraram a produção de sete variantes de microcistina (MC-LR, MC-LL, MC-LA, MC-LM, MC-FR, MC-LAba e [D-Asp3]Mc-LL), essas duas últimas raramente descritas pela literatura. Os bioensaios mostraram bioatividade dos extratos intracelular polar e apolar contra Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium, Burkholderia cepacia, Xanthomonas campestris e Candida albicans. A coleta das frações do extrato apolar por cromatografia líquida revelou bioatividade em três diferentes tempos de aquisição. As frações coletadas do extrato polar evidenciaram o pico de microcistina, constatada a partir da linhagem CENA161 axênica, inclusive. Nossos resultados revelaram a presença de agrupamentos gênicos de síntese de moléculas bioativas e a habilidade da linhagem Fischerella sp. CENA161 em produzir diferentes substâncias bioativas, sintetizadas pela via ribossomal e não ribossomal, em condições axênicas. / Fischerella is a cyanobacterial genus that occurs in several subaerophytic environments and presents ecological, evolutive, biogeochemical, biotechnologic and ecotoxicologic importance. The study of the genome can leads to the better compreension about its metabolism and its ability to produce cyanotoxins and other bioactive molecules. The Fischerella sp. strain CENA161 was isolated from a spring water in Piracicaba, and it was identified microcystin peptide hepatotoxic producer. That was the first report about the production of the toxin by this cyanobacterial genus. The aim of this study was to sequence the genome of the cyanobacteria Fischerella sp. strain CENA161 and perform the assembly and annotation of the genes involved in its secondary metabolism. For this, the strain was previously treated with 0,5 % sodium hypochlorite to remove the heterothrophic bacteria, followed with exhaustion from the short filaments in Petri plates, searching isolate the strain. The deoxirribonucleic acid was extracted from the CENA161 cells cultivated in Erlenmeyers with BG-110 liquid media. The genomic library was performed by MiSeq sequencing, and the ab initio assembly was performed with the reads obtained from the sequencing. The gene annotation and prediction were performed with the antiSMASH tool, for the secondary metabolites screening, and the nucleotides sequences alignment was performed using known genes present in other cyanobacteria producers and the CENA161 genome, using the BLASTN tool. The bioactive compounds produced by the strain were investigated with bioassays against bacteria and fungi, and also using high performance liquid chromatography with mass spectrometry. The results revealed the Fischerella sp. strain CENA161 presents the microcystins gene cluster in its genome, with the ten genes that were described in the first time (mcyA-mcyJ), and showed high identity in your sequences with the Fischerella sp. PCC 9339 sequences, although the synteny is very close to Nostoc sp. strain 152 microcystin gene cluster. We also found the ambiguine gene cluster (amb), that showed 25 genes out of 32 genes of total from the Fischerella sp. strain UTEX 1903, with high identity (98 %) among the nucleotide sequences. We found six genes out of eight that compose the nostopeptolide gene cluster (nos) described for Nostoc sp. strain GSV224, but presenting differentiated synteny for the CENA161. The chemical analyses by mass spectrometry showed the production of seven microcystin variants (MC-LR, MC-LL, MC-LA, MC-LM, MC-FR, MCLAba and [D-Asp3]Mc-LL), the last two ones being rarely described by literature. The bioassays showed bioactivity from the polar and nonpolar intracellular extracts against Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium, Burkholderia cepacia, Xanthomonas campestris and Candida albicans. The collect of the peaks from the nonpolar extract in HPLC revealed bioactivity in three different acquisition times. The peaks collected from the polar extract did not show bioactivity, but the running in HPLC showed the peak corresponding to microcystin, produced by axenic CENA161 strain. Our results revealed the presence of some gene clusters involved in the bioactive molecules synthesis and the ability for the Fischerella sp. strain CENA161 to produce different bioactive compounds, synthesized by ribosomal and nonribosomal pathway, in non-axenic and axenic condictions.

Fischerella é um gênero cianobacteriano de ocorrência em diversos ambientes subaerofíticos que apresenta importância ecológica, evolutiva, biogeoquímica, biotecnológica e ecotoxicológica. O estudo de seu genoma pode levar a uma melhor compreensão de seu metabolismo secundário e de sua capacidade de produção de cianotoxinas e outras moléculas bioativas. A linhagem Fischerella CENA161, isolada de uma nascente de água na região de Piracicaba, foi identificada como produtora do peptídeo hepatotóxico microcistina. Este foi o primeiro relato da produção dessa toxina por esse gênero de cianobactéria. Dessa maneira, este trabalho teve como objetivo sequenciar o genoma da cianobactéria Fischerella CENA161 e realizar sua montagem e a anotação de genes envolvidos com seu metabolismo secundário. Para isso, a linhagem foi tratada com hipoclorito de sódio para remover as bactérias heterotróficas, com posterior esgotamento de pequenos fragmentos em placa de cultura sólida, de forma a isolar a linhagem. Foi realizada a extração de ácido desoxirribonucleico das células tratadas da CENA161 cultivadas em Erlenmeyers contendo meio de cultura líquido BG-110. Uma biblioteca genômica foi construída para o sequenciamento MiSeq e, então, foi realizada a montagem ab initio do genoma com as leituras obtidas. A anotação de genes foi realizada utilizando a ferramenta antiSMASH, para a predição de metabólitos secundários, e também foi realizado o alinhamento de sequências nucleotídicas já conhecidas de outras linhagens contra o genoma da CENA161, utilizando a ferramenta BLASTN. As moléculas bioativas produzidas pela linhagem foram investigadas através de bioensaios contra bactérias e fungo, e utilizando cromatografia líquida de alta pressão e espectrometria de massas. Os resultados mostraram que a linhagem CENA161 possui, em seu genoma, o agrupamento gênico de biossíntese da microcistina, apresentando os 10 genes descritos primeiramente (mcyA-mcyJ), e alta identidade de suas sequências com as sequências da linhagem Fischerella sp. PCC 9339, embora sua sintenia gênica esteja mais próxima à da linhagem Nostoc sp. 152. Ainda, foram anotados os agrupamentos gênicos de biossíntese de ambiguina (amb), apresentando 25 genes do total de 32 genes descritos para a linhagem Fischerella sp. UTEX 1903, com identidade mínima de 98 % entre as sequências nucleotídicas. Foram encontrados, também, seis genes do total de oito que formam o agrupamento de biossíntese de nostopeptolida (nos), descrito para Nostoc sp. GSV224, e com sintenia diferenciada para a linhagem CENA161. As análises químicas de espectrometria de massas mostraram a produção de sete variantes de microcistina (MC-LR, MC-LL, MC-LA, MC-LM, MC-FR, MC-LAba e [D-Asp3]Mc-LL), essas duas últimas raramente descritas pela literatura. Os bioensaios mostraram bioatividade dos extratos intracelular polar e apolar contra Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium, Burkholderia cepacia, Xanthomonas campestris e Candida albicans. A coleta das frações do extrato apolar por cromatografia líquida revelou bioatividade em três diferentes tempos de aquisição. As frações coletadas do extrato polar evidenciaram o pico de microcistina, constatada a partir da linhagem CENA161 axênica, inclusive. Nossos resultados revelaram a presença de agrupamentos gênicos de síntese de moléculas bioativas e a habilidade da linhagem Fischerella sp. CENA161 em produzir diferentes substâncias bioativas, sintetizadas pela via ribossomal e não ribossomal, em condições axênicas. / Fischerella is a cyanobacterial genus that occurs in several subaerophytic environments and presents ecological, evolutive, biogeochemical, biotechnologic and ecotoxicologic importance. The study of the genome can leads to the better compreension about its metabolism and its ability to produce cyanotoxins and other bioactive molecules. The Fischerella sp. strain CENA161 was isolated from a spring water in Piracicaba, and it was identified microcystin peptide hepatotoxic producer. That was the first report about the production of the toxin by this cyanobacterial genus. The aim of this study was to sequence the genome of the cyanobacteria Fischerella sp. strain CENA161 and perform the assembly and annotation of the genes involved in its secondary metabolism. For this, the strain was previously treated with 0,5 % sodium hypochlorite to remove the heterothrophic bacteria, followed with exhaustion from the short filaments in Petri plates, searching isolate the strain. The deoxirribonucleic acid was extracted from the CENA161 cells cultivated in Erlenmeyers with BG-110 liquid media. The genomic library was performed by MiSeq sequencing, and the ab initio assembly was performed with the reads obtained from the sequencing. The gene annotation and prediction were performed with the antiSMASH tool, for the secondary metabolites screening, and the nucleotides sequences alignment was performed using known genes present in other cyanobacteria producers and the CENA161 genome, using the BLASTN tool. The bioactive compounds produced by the strain were investigated with bioassays against bacteria and fungi, and also using high performance liquid chromatography with mass spectrometry. The results revealed the Fischerella sp. strain CENA161 presents the microcystins gene cluster in its genome, with the ten genes that were described in the first time (mcyA-mcyJ), and showed high identity in your sequences with the Fischerella sp. PCC 9339 sequences, although the synteny is very close to Nostoc sp. strain 152 microcystin gene cluster. We also found the ambiguine gene cluster (amb), that showed 25 genes out of 32 genes of total from the Fischerella sp. strain UTEX 1903, with high identity (98 %) among the nucleotide sequences. We found six genes out of eight that compose the nostopeptolide gene cluster (nos) described for Nostoc sp. strain GSV224, but presenting differentiated synteny for the CENA161. The chemical analyses by mass spectrometry showed the production of seven microcystin variants (MC-LR, MC-LL, MC-LA, MC-LM, MC-FR, MCLAba and [D-Asp3]Mc-LL), the last two ones being rarely described by literature. The bioassays showed bioactivity from the polar and nonpolar intracellular extracts against Staphylococcus aureus, Bacillus cereus, Salmonella typhimurium, Burkholderia cepacia, Xanthomonas campestris and Candida albicans. The collect of the peaks from the nonpolar extract in HPLC revealed bioactivity in three different acquisition times. The peaks collected from the polar extract did not show bioactivity, but the running in HPLC showed the peak corresponding to microcystin, produced by axenic CENA161 strain. Our results revealed the presence of some gene clusters involved in the bioactive molecules synthesis and the ability for the Fischerella sp. strain CENA161 to produce different bioactive compounds, synthesized by ribosomal and nonribosomal pathway, in non-axenic and axenic condictions.

<p>Nonribosomal peptides, polyketides, and fatty acids comprise a distinct subset of microbial secondary metabolites produced by similar biosynthetic methods and exhibit broad structural diversity with a high propensity for biological activity. Dedicated studies of these specific microbial small molecules have identified numerous potent actions towards human cells with many clinical translations. Interestingly, most therapeutically used nonribosomal peptides and polyketides were discovered from soil bacteria, meanwhile, bacteria that have co-evolved within a human context, the human microbiota, have barely been explored for secondary metabolites. The central goal of this thesis is to explore the secondary metabolome of human microbiota for nonribosomal peptides and polyketides, which are hypothesized to possess biological activities significant within the human host context. Candidate organisms were chosen for their established connections to human health and evidence suggestive of secondary metabolite production. Specifically, questions about gene to molecule prediction capability, metabolite production, structural diversity, and biological activity were explored from studies of the dental caries linked Streptococcus mutans UA159, from the probiotic Lactobacillus plantarum WCFS1, and the Crohn’s disease associated Faecalibacterium prausnitzii.</p> / Master of Science (MSc)